MXPA05010498A - Preparacion de clorhidrato de quinapril. - Google Patents
Preparacion de clorhidrato de quinapril.Info
- Publication number
- MXPA05010498A MXPA05010498A MXPA05010498A MXPA05010498A MXPA05010498A MX PA05010498 A MXPA05010498 A MX PA05010498A MX PA05010498 A MXPA05010498 A MX PA05010498A MX PA05010498 A MXPA05010498 A MX PA05010498A MX PA05010498 A MXPA05010498 A MX PA05010498A
- Authority
- MX
- Mexico
- Prior art keywords
- quinapril
- preparation
- butyl ester
- acid
- tert
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D217/00—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems
- C07D217/22—Heterocyclic compounds containing isoquinoline or hydrogenated isoquinoline ring systems with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the nitrogen-containing ring
- C07D217/26—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/221—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having an amino group, e.g. acetylcholine, acetylcarnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/472—Non-condensed isoquinolines, e.g. papaverine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Cardiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Hospice & Palliative Care (AREA)
- Emergency Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Other In-Based Heterocyclic Compounds (AREA)
Abstract
Se describen procedimientos y materiales para preparar quinapril, sus sales farmaceuticamente aceptables, incluyendo clorhidrato de quinapril; el procedimiento incluye hacer reaccionar el ester etilico del acido (2S,4S)-2-(4-metil-2,5-dioxo-oxazolidin-3-il)-4-fenilbutirico con el ester tercbutilico del acido (3S)-1,2,3,4-tetrahidro-isoquinolin-3-carboxilico para dar el ester ter-butilico de quinapril, el cual se hace reaccionar posteriormente con un acido para dar quinapril o una sal de adicion de acido de quinapril.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US45901603P | 2003-03-31 | 2003-03-31 | |
PCT/IB2004/000942 WO2004087671A1 (en) | 2003-03-31 | 2004-03-19 | Preparation of quinapril hydrochloride |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA05010498A true MXPA05010498A (es) | 2005-11-16 |
Family
ID=33131855
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA05010498A MXPA05010498A (es) | 2003-03-31 | 2004-03-19 | Preparacion de clorhidrato de quinapril. |
Country Status (22)
Country | Link |
---|---|
US (1) | US6858735B2 (es) |
EP (1) | EP1611106B1 (es) |
JP (1) | JP2006522092A (es) |
KR (1) | KR20050115323A (es) |
CN (1) | CN1747935A (es) |
AR (1) | AR043949A1 (es) |
AT (1) | ATE340161T1 (es) |
AU (1) | AU2004226154B2 (es) |
BR (1) | BRPI0408924A (es) |
CA (1) | CA2517451C (es) |
CL (1) | CL2004000541A1 (es) |
DE (1) | DE602004002473T2 (es) |
DK (1) | DK1611106T3 (es) |
ES (1) | ES2271868T3 (es) |
MX (1) | MXPA05010498A (es) |
PL (1) | PL1611106T3 (es) |
PT (1) | PT1611106E (es) |
RS (1) | RS20050597A (es) |
RU (1) | RU2298004C2 (es) |
TW (1) | TWI284637B (es) |
WO (1) | WO2004087671A1 (es) |
ZA (1) | ZA200505214B (es) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2009053994A1 (en) * | 2007-10-26 | 2009-04-30 | Matrix Laboratories Limited | Process for preparing pure amorphous quinapril hydrochloride |
US10278742B2 (en) | 2012-11-12 | 2019-05-07 | DePuy Synthes Products, Inc. | Interbody interference implant and instrumentation |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4344949A (en) * | 1980-10-03 | 1982-08-17 | Warner-Lambert Company | Substituted acyl derivatives of 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acids |
US4686295A (en) * | 1982-03-10 | 1987-08-11 | Usv Pharmaceutical Corporation | N-carboxy anhydride intermediates |
US4761479A (en) * | 1987-03-30 | 1988-08-02 | Warner-Lambert Company | Crystalline quinapril and a process for producing the same |
WO2002018321A2 (en) * | 2000-08-29 | 2002-03-07 | Abbott Laboratories | Amino(oxo)acetic acid protein tyrosine phosphatase inhibitors |
US6541635B1 (en) * | 2002-03-29 | 2003-04-01 | Everlight Usa, Inc. | Method for producing angiotensin converting enzyme inhibitor |
CA2510773C (en) * | 2002-12-16 | 2010-04-13 | Lupin Limited | Crystalline form of quinapril hydrochloride and process for preparing the same |
-
2004
- 2004-03-16 CL CL200400541A patent/CL2004000541A1/es unknown
- 2004-03-19 EP EP04721968A patent/EP1611106B1/en not_active Expired - Lifetime
- 2004-03-19 PT PT04721968T patent/PT1611106E/pt unknown
- 2004-03-19 CN CNA2004800040018A patent/CN1747935A/zh active Pending
- 2004-03-19 WO PCT/IB2004/000942 patent/WO2004087671A1/en active IP Right Grant
- 2004-03-19 CA CA002517451A patent/CA2517451C/en not_active Expired - Fee Related
- 2004-03-19 RU RU2005130402/04A patent/RU2298004C2/ru not_active IP Right Cessation
- 2004-03-19 KR KR1020057018421A patent/KR20050115323A/ko not_active Application Discontinuation
- 2004-03-19 PL PL04721968T patent/PL1611106T3/pl unknown
- 2004-03-19 AT AT04721968T patent/ATE340161T1/de not_active IP Right Cessation
- 2004-03-19 BR BRPI0408924-3A patent/BRPI0408924A/pt not_active IP Right Cessation
- 2004-03-19 RS YUP-2005/0597A patent/RS20050597A/sr unknown
- 2004-03-19 JP JP2006506407A patent/JP2006522092A/ja not_active Withdrawn
- 2004-03-19 ES ES04721968T patent/ES2271868T3/es not_active Expired - Lifetime
- 2004-03-19 AU AU2004226154A patent/AU2004226154B2/en not_active Ceased
- 2004-03-19 DK DK04721968T patent/DK1611106T3/da active
- 2004-03-19 MX MXPA05010498A patent/MXPA05010498A/es not_active Application Discontinuation
- 2004-03-19 DE DE602004002473T patent/DE602004002473T2/de not_active Expired - Fee Related
- 2004-03-23 US US10/806,707 patent/US6858735B2/en not_active Expired - Fee Related
- 2004-03-29 AR ARP040101036A patent/AR043949A1/es not_active Application Discontinuation
- 2004-03-30 TW TW093108753A patent/TWI284637B/zh not_active IP Right Cessation
-
2005
- 2005-06-28 ZA ZA200505214A patent/ZA200505214B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
AU2004226154B2 (en) | 2007-03-08 |
AU2004226154A1 (en) | 2004-10-14 |
US6858735B2 (en) | 2005-02-22 |
TW200424177A (en) | 2004-11-16 |
TWI284637B (en) | 2007-08-01 |
CL2004000541A1 (es) | 2005-02-04 |
WO2004087671A1 (en) | 2004-10-14 |
US20040192613A1 (en) | 2004-09-30 |
CA2517451C (en) | 2009-04-21 |
KR20050115323A (ko) | 2005-12-07 |
DE602004002473T2 (de) | 2007-06-14 |
PT1611106E (pt) | 2006-11-30 |
ES2271868T3 (es) | 2007-04-16 |
JP2006522092A (ja) | 2006-09-28 |
RU2005130402A (ru) | 2006-02-10 |
DK1611106T3 (da) | 2006-12-27 |
EP1611106B1 (en) | 2006-09-20 |
ZA200505214B (en) | 2008-08-27 |
CA2517451A1 (en) | 2004-10-14 |
RU2298004C2 (ru) | 2007-04-27 |
AR043949A1 (es) | 2005-08-17 |
PL1611106T3 (pl) | 2007-01-31 |
ATE340161T1 (de) | 2006-10-15 |
EP1611106A1 (en) | 2006-01-04 |
BRPI0408924A (pt) | 2006-04-04 |
DE602004002473D1 (de) | 2006-11-02 |
RS20050597A (en) | 2007-09-21 |
CN1747935A (zh) | 2006-03-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2665931C (en) | Hydrobenzamide derivatives as inhibitors of hsp90 | |
MY141224A (en) | Crystalline form of a biphenyl compound | |
TW200728307A (en) | Novel spirochromanone derivatives | |
WO2002010154A3 (en) | Substituted heterocyclic amides | |
WO2020016749A3 (en) | Chemical process for preparing phenylpiperidinyl indole derivatives | |
EP1961748A3 (en) | 2-Hydroxy-3-heteroarylindole derivatives as GSK3 inhibitors | |
NZ603236A (en) | Boronate ester compounds and pharmaceutical compositions thereof | |
EA200400606A1 (ru) | ИНГИБИТОРЫ ФАКТОРА Ха И ДРУГИХ СЕРИНОВЫХ ПРОТЕАЗ, ВОВЛЕЧЁННЫХ В КОАГУЛЯЦИОННЫЙ КАСКАД | |
WO2005105749A3 (en) | Process for making montelukast and intermediates therefor | |
WO2005046589A3 (en) | Pharmaceutically acceptable salts of quinolinone compounds having improved pharmaceutical properties | |
EP2308828A3 (en) | CaSR antagonist | |
EP2153832A3 (en) | Heterocyclic aspartyl protease inhibitors | |
WO2004054505A3 (en) | Method of using aminocyanopyridine compounds as mitogen activated protein kinase-activated protein kinase-2 inhibitors | |
WO2007109578A3 (en) | Substituted gamma lactams as prostaglandin ep2 agonists | |
MX2021014855A (es) | {6-[(2-amino-3-cloropiridin-4-il)sulfanil]-3-[(3s,4s)-4-amino-3-m etil-2 oxa-8-azaspiro[4.5]decan-8-il]-5-metilpirazin-2-il}metanol, un inhibidor de shp2. | |
NO20072515L (no) | 2-amido-4-fenyltnazolderivater, fremstilling og terapeutsik anvendelse derav | |
WO2007057225A3 (en) | Process for making montelukast and intermediates therefor | |
TW200745097A (en) | 4-Phenyl-thiazole-5-carboxylic acids and 4-phenyl-thiazole-5-carboxylic acid amides as PLK1 inhibitors | |
UA95223C2 (ru) | Производные пиридопиримидина, их получение, их применение в терапии | |
EP2404913A3 (en) | Process and intermediates for the preparation of antitumoral dihydropyran-2-one compounds | |
MY133527A (en) | Isoquinoline derivatives | |
WO2004000785A3 (en) | Phenyloxyalkanonic acid derivatives as hppar activators | |
WO2004043920A8 (en) | Polymorphs of bicifadine hydrochloride | |
AU2001272504A1 (en) | 4-alkoxy cyclohexane-1 amino carboxylic acid esters and method for the production thereof | |
AU2003241060A1 (en) | New atorvastatin salts and pharmaceutical compositions containing them |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal |